Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Fourier Transform Infrared Spectrophotometer

By Drug Discovery Trends Editor | September 12, 2008

Shimadzu IRAffinity-1Shimadzu Scientific Instruments designed the IRAffinity-1 Fourier Transform Infrared (FTIR) spectrophotometer with high-throughput optics and a dynamic alignment mechanism to increase sensitivity, stability and usability. The IRAffinity-1 is ideal for high-precision infrared analysis to confirm, identify and detect foreign matter in raw materials, medical products, packages and coatings.

The IRAffinity-1 offers high signal-to-noise ratio (sensitivity) at 30,000:1, with a maximum resolution of 0.5 cm-1 (according to Shimadzu’s investigation in January 2008). The unit achieves this level of sensitivity by using a high-energy ceramic light source; temperature-controlled, high-sensitivity DLATGS detector; and high-throughput optical elements. Also, the IRAffinity-1 includes optimized electrical and optical systems to minimize noise levels.

The IRAffinity-1 includes patented technology to increase stability and precision. Its moving mirror is run smoothly and precisely by a flexible joint system patented by Shimadzu. The interferometer is optimized and stabilized by a dynamic alignment mechanism on which Shimadzu has a patent pending. The interferometer’s optical elements are protected from humidity and stabilized by a sealed interferometer, as well as by continuously removing moisture by a reactive polymeric desiccator, and coating the beam splitter with moisture-resistant protective film.

www.ssi.shimadzu.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50